Stocksigma LogoStocksigma Logo

Fermenta Biotech Reports Q2/H1FY27 Performance and Growth Pipeline Updates

Fermenta Biotech reported flat Q2FY27 consolidated revenue of INR 135.8 crore (up 0.1% YoY, up 8% QoQ) and EBITDA of INR 23.2 crore (down 28% YoY)

Fermenta Biotech Reports Q2/H1FY27 Performance and Growth Pipeline Updates

Fermenta Biotech Ltd 路 Investor Presentation 路 06 Nov 2026, 4:44 pm

Fermenta Biotech Reports Q2/H1FY27 Performance and Growth Pipeline Updates Fermenta Biotech reported flat Q2FY27 consolidated revenue of INR 135.8 crore (up 0.1% YoY, up 8% QoQ) and EBITDA of INR 23.2 crore (down 28% YoY), impacted by animal nutrition price normalization and elevated prior-year one-offs. H1FY27 revenue fell 7% YoY to INR 261.9 crore, while PAT declined 52% YoY to INR 18.9 crore. Despite profitability pressures, operating cash flow grew 44% to INR 54.8 crore, reducing net debt below INR 3 crore. Growth initiatives progressed with FSSAI approval for VITADEE Green庐, targeting commercial capacity by Q2FY28.

Original exchange filing (PDF)

More announcements from Fermenta Biotech Ltd

All Fermenta Biotech Ltd announcements